Silverarc Capital Management’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
2022
Q4
$2.62M Buy
2022
Q3
$627K Sell
2022
Q2
$5.76M Buy
2022
Q1
$7.1K Buy
2021
Q4
$6.65M Buy
2021
Q3
$5.75M Buy
2021
Q2
$4.68K Buy
2021
Q1
$4.46M Buy
2020
Q4
$2.19M Buy